Non-receptor tyrosine kinases as molecular targets for patient tailored cancer therapy.
Uckun
Fatih M
FM
Parker Hughes Cancer Center & Parker Hughes Institute, St. Paul, MN, USA. fatih_uckun@ih.org.
Vassilev
A
A
Tibbles
H
H
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology; D047428:Protein Kinase Inhibitors / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000187:drug effects*
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases